NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $569,233 | -75.8% | 4,900 | -64.0% | 0.00% | -77.8% |
Q4 2020 | $2,353,344 | +13.4% | 13,600 | -61.1% | 0.02% | -25.0% |
Q2 2020 | $2,076,000 | +606.1% | 35,000 | +472.6% | 0.02% | +1100.0% |
Q1 2019 | $294,000 | -95.4% | 6,113 | -98.1% | 0.00% | -95.3% |
Q3 2017 | $6,451,000 | +7579.8% | 325,000 | +3026.8% | 0.04% | +4200.0% |
Q1 2017 | $84,000 | – | 10,394 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |